avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf4
|
ENSMUSG00000003032.9 | Klf4 |
Sp3
|
ENSMUSG00000027109.17 | Sp3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp3 | mm39_v1_chr2_-_72810782_72810811 | 0.74 | 2.6e-07 | Click! |
Klf4 | mm39_v1_chr4_-_55532453_55532485 | 0.63 | 3.6e-05 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_37806912 | 47.07 |
ENSMUST00000108023.10
|
Ccne1
|
cyclin E1 |
chr7_-_142211203 | 45.88 |
ENSMUST00000097936.9
ENSMUST00000000033.12 |
Igf2
|
insulin-like growth factor 2 |
chr11_-_116472272 | 40.11 |
ENSMUST00000082152.5
|
Ube2o
|
ubiquitin-conjugating enzyme E2O |
chr7_-_143014726 | 39.20 |
ENSMUST00000167912.9
ENSMUST00000037287.8 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr7_-_4755971 | 38.72 |
ENSMUST00000183971.8
ENSMUST00000182173.2 ENSMUST00000182738.8 ENSMUST00000182111.8 ENSMUST00000184143.8 ENSMUST00000182048.2 ENSMUST00000063324.14 |
Cox6b2
|
cytochrome c oxidase subunit 6B2 |
chr11_+_61967821 | 38.18 |
ENSMUST00000092415.9
ENSMUST00000201015.4 ENSMUST00000202744.4 ENSMUST00000201723.4 ENSMUST00000202179.2 |
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr4_+_156046745 | 36.51 |
ENSMUST00000024338.5
|
C1qtnf12
|
C1q and tumor necrosis factor related 12 |
chr10_-_81214293 | 34.31 |
ENSMUST00000140901.8
|
Fzr1
|
fizzy and cell division cycle 20 related 1 |
chrX_-_7834057 | 33.97 |
ENSMUST00000033502.14
|
Gata1
|
GATA binding protein 1 |
chr2_-_131001916 | 32.90 |
ENSMUST00000103188.10
ENSMUST00000133602.8 ENSMUST00000028800.12 |
1700037H04Rik
|
RIKEN cDNA 1700037H04 gene |
chr6_-_72935171 | 32.60 |
ENSMUST00000114049.2
|
Tmsb10
|
thymosin, beta 10 |
chr6_-_72935468 | 30.52 |
ENSMUST00000114050.8
|
Tmsb10
|
thymosin, beta 10 |
chr7_-_142223662 | 29.96 |
ENSMUST00000228850.2
|
Gm49394
|
predicted gene, 49394 |
chr9_-_109678685 | 29.69 |
ENSMUST00000112022.5
|
Camp
|
cathelicidin antimicrobial peptide |
chr4_-_43040278 | 29.63 |
ENSMUST00000107958.8
ENSMUST00000107959.8 ENSMUST00000152846.8 |
Fam214b
|
family with sequence similarity 214, member B |
chr11_+_74510413 | 29.43 |
ENSMUST00000100866.3
|
Ccdc92b
|
coiled-coil domain containing 92B |
chr2_+_162896602 | 29.02 |
ENSMUST00000018005.10
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr9_+_20940669 | 29.00 |
ENSMUST00000001040.7
ENSMUST00000215077.2 |
Icam4
|
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
chr15_-_103163860 | 28.83 |
ENSMUST00000075192.13
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr7_-_16796309 | 28.00 |
ENSMUST00000153833.2
ENSMUST00000108492.9 |
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr6_-_72935382 | 27.94 |
ENSMUST00000144337.2
|
Tmsb10
|
thymosin, beta 10 |
chr3_-_100396635 | 27.00 |
ENSMUST00000061455.9
|
Tent5c
|
terminal nucleotidyltransferase 5C |
chr10_-_128236317 | 26.97 |
ENSMUST00000167859.2
ENSMUST00000218858.2 |
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr8_+_85628557 | 26.94 |
ENSMUST00000067060.10
ENSMUST00000239392.2 |
Klf1
|
Kruppel-like factor 1 (erythroid) |
chr2_+_131028861 | 26.74 |
ENSMUST00000028804.15
ENSMUST00000079857.9 |
Cdc25b
|
cell division cycle 25B |
chr14_-_79539063 | 26.15 |
ENSMUST00000022595.8
|
Rgcc
|
regulator of cell cycle |
chr7_+_16515265 | 25.86 |
ENSMUST00000108496.9
|
Slc1a5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
chr6_+_90581681 | 25.23 |
ENSMUST00000044019.16
|
Slc41a3
|
solute carrier family 41, member 3 |
chr17_+_29709723 | 24.80 |
ENSMUST00000024811.9
|
Pim1
|
proviral integration site 1 |
chr7_-_142209755 | 24.70 |
ENSMUST00000178921.2
|
Igf2
|
insulin-like growth factor 2 |
chr10_-_128236366 | 24.44 |
ENSMUST00000219131.2
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr9_+_110848339 | 24.02 |
ENSMUST00000198884.5
ENSMUST00000196777.5 ENSMUST00000196209.5 ENSMUST00000035077.8 ENSMUST00000196122.3 |
Ltf
|
lactotransferrin |
chr11_-_69496655 | 24.01 |
ENSMUST00000047889.13
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr4_-_133615075 | 23.91 |
ENSMUST00000003741.16
ENSMUST00000105894.11 |
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr7_+_100142544 | 23.65 |
ENSMUST00000126534.8
ENSMUST00000207748.2 |
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr11_-_102255999 | 23.55 |
ENSMUST00000006749.10
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr4_+_120523758 | 23.52 |
ENSMUST00000094814.6
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr5_-_114046746 | 23.47 |
ENSMUST00000004646.13
|
Coro1c
|
coronin, actin binding protein 1C |
chr7_+_79944198 | 23.43 |
ENSMUST00000163812.9
ENSMUST00000047558.14 ENSMUST00000174199.8 ENSMUST00000173824.8 ENSMUST00000174172.8 |
Prc1
|
protein regulator of cytokinesis 1 |
chr12_-_4891435 | 23.34 |
ENSMUST00000219880.2
ENSMUST00000020964.7 |
Fkbp1b
|
FK506 binding protein 1b |
chr7_+_100142977 | 22.98 |
ENSMUST00000129324.8
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr14_-_69522431 | 22.78 |
ENSMUST00000183882.2
ENSMUST00000037064.5 |
Slc25a37
|
solute carrier family 25, member 37 |
chr14_-_60324265 | 22.75 |
ENSMUST00000080368.13
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr11_+_78192355 | 22.53 |
ENSMUST00000045026.4
|
Spag5
|
sperm associated antigen 5 |
chr9_-_107863062 | 22.33 |
ENSMUST00000048568.6
|
Inka1
|
inka box actin regulator 1 |
chr9_+_59563872 | 21.91 |
ENSMUST00000215623.2
ENSMUST00000215660.2 ENSMUST00000217353.2 |
Pkm
|
pyruvate kinase, muscle |
chr17_-_57137898 | 21.90 |
ENSMUST00000233000.2
ENSMUST00000002444.15 ENSMUST00000086801.7 |
Rfx2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr7_+_13012735 | 21.84 |
ENSMUST00000098814.13
ENSMUST00000146998.9 |
Lig1
|
ligase I, DNA, ATP-dependent |
chrX_-_134968985 | 21.82 |
ENSMUST00000049130.8
|
Bex2
|
brain expressed X-linked 2 |
chrX_-_73289970 | 21.81 |
ENSMUST00000130007.8
|
Flna
|
filamin, alpha |
chr6_-_39397212 | 21.75 |
ENSMUST00000114822.2
ENSMUST00000051671.11 |
Mkrn1
|
makorin, ring finger protein, 1 |
chr9_-_65487322 | 21.67 |
ENSMUST00000068944.9
|
Plekho2
|
pleckstrin homology domain containing, family O member 2 |
chrX_-_73290140 | 21.65 |
ENSMUST00000101454.9
ENSMUST00000033699.13 |
Flna
|
filamin, alpha |
chr2_+_29759495 | 21.19 |
ENSMUST00000047521.7
ENSMUST00000134152.2 |
Cercam
|
cerebral endothelial cell adhesion molecule |
chr7_+_24069680 | 21.11 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr2_+_172864153 | 20.94 |
ENSMUST00000173997.2
|
Rbm38
|
RNA binding motif protein 38 |
chr10_-_80413119 | 20.87 |
ENSMUST00000038558.9
|
Klf16
|
Kruppel-like factor 16 |
chr19_-_41790458 | 20.35 |
ENSMUST00000026150.15
ENSMUST00000163265.9 ENSMUST00000177495.2 |
Arhgap19
|
Rho GTPase activating protein 19 |
chr9_-_21874802 | 20.28 |
ENSMUST00000006397.7
|
Epor
|
erythropoietin receptor |
chr12_-_69274936 | 20.17 |
ENSMUST00000221411.2
ENSMUST00000021359.7 |
Pole2
|
polymerase (DNA directed), epsilon 2 (p59 subunit) |
chr8_+_86026318 | 20.12 |
ENSMUST00000170141.3
ENSMUST00000034132.13 |
Orc6
|
origin recognition complex, subunit 6 |
chr4_+_114914880 | 20.06 |
ENSMUST00000161601.8
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr1_+_136059101 | 19.90 |
ENSMUST00000075164.11
|
Kif21b
|
kinesin family member 21B |
chr7_-_80453033 | 19.62 |
ENSMUST00000167377.3
|
Iqgap1
|
IQ motif containing GTPase activating protein 1 |
chr17_+_36172210 | 19.59 |
ENSMUST00000074259.15
ENSMUST00000174873.2 |
Nrm
|
nurim (nuclear envelope membrane protein) |
chr6_+_30738043 | 19.53 |
ENSMUST00000163949.9
ENSMUST00000124665.3 |
Mest
|
mesoderm specific transcript |
chr8_-_72178340 | 19.33 |
ENSMUST00000153800.8
ENSMUST00000146100.8 |
Fcho1
|
FCH domain only 1 |
chr4_+_108436639 | 19.13 |
ENSMUST00000102744.4
|
Orc1
|
origin recognition complex, subunit 1 |
chr2_-_25911691 | 19.11 |
ENSMUST00000036509.14
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr1_-_167221344 | 18.99 |
ENSMUST00000028005.3
|
Mgst3
|
microsomal glutathione S-transferase 3 |
chr9_-_21202353 | 18.88 |
ENSMUST00000086374.8
|
Cdkn2d
|
cyclin dependent kinase inhibitor 2D |
chr10_-_5755412 | 18.86 |
ENSMUST00000019907.8
|
Fbxo5
|
F-box protein 5 |
chr19_+_6135013 | 18.55 |
ENSMUST00000025704.3
|
Cdca5
|
cell division cycle associated 5 |
chr5_+_140491305 | 18.45 |
ENSMUST00000043050.9
ENSMUST00000124142.2 |
Chst12
|
carbohydrate sulfotransferase 12 |
chr6_-_39397334 | 18.42 |
ENSMUST00000031985.13
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr7_-_97827461 | 18.37 |
ENSMUST00000040971.14
|
Capn5
|
calpain 5 |
chr11_-_69838971 | 18.37 |
ENSMUST00000179298.3
ENSMUST00000018710.13 ENSMUST00000135437.3 ENSMUST00000141837.9 ENSMUST00000142500.8 |
Slc2a4
|
solute carrier family 2 (facilitated glucose transporter), member 4 |
chr4_-_154110073 | 18.30 |
ENSMUST00000182191.8
ENSMUST00000146543.9 ENSMUST00000146426.2 |
Smim1
|
small integral membrane protein 1 |
chrX_+_72683020 | 18.29 |
ENSMUST00000019701.9
|
Dusp9
|
dual specificity phosphatase 9 |
chr10_+_80097290 | 18.20 |
ENSMUST00000156935.8
|
Dazap1
|
DAZ associated protein 1 |
chr4_-_43045685 | 18.12 |
ENSMUST00000107956.8
ENSMUST00000107957.8 |
Fam214b
|
family with sequence similarity 214, member B |
chr14_-_70867588 | 18.12 |
ENSMUST00000228009.2
|
Dmtn
|
dematin actin binding protein |
chr8_+_123008855 | 18.11 |
ENSMUST00000054052.15
|
Zfpm1
|
zinc finger protein, multitype 1 |
chr5_+_35106778 | 18.01 |
ENSMUST00000030984.14
|
Rgs12
|
regulator of G-protein signaling 12 |
chr4_-_133856025 | 17.96 |
ENSMUST00000105879.2
ENSMUST00000030651.9 |
Sh3bgrl3
|
SH3 domain binding glutamic acid-rich protein-like 3 |
chr7_-_4815111 | 17.93 |
ENSMUST00000205885.2
|
Ube2s
|
ubiquitin-conjugating enzyme E2S |
chr10_-_12839995 | 17.90 |
ENSMUST00000219727.2
ENSMUST00000163425.9 ENSMUST00000042861.7 ENSMUST00000218685.2 |
Stx11
|
syntaxin 11 |
chr12_-_32111214 | 17.87 |
ENSMUST00000003079.12
ENSMUST00000036497.16 |
Prkar2b
|
protein kinase, cAMP dependent regulatory, type II beta |
chr11_+_78234300 | 17.79 |
ENSMUST00000002127.14
ENSMUST00000108295.8 |
Unc119
|
unc-119 lipid binding chaperone |
chr17_+_35278011 | 17.71 |
ENSMUST00000007255.13
ENSMUST00000174493.8 |
Ddah2
|
dimethylarginine dimethylaminohydrolase 2 |
chr7_+_27147403 | 17.65 |
ENSMUST00000037399.16
ENSMUST00000108358.8 |
Blvrb
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr7_+_100145192 | 17.61 |
ENSMUST00000133044.3
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr15_+_78810919 | 17.51 |
ENSMUST00000089377.6
|
Lgals1
|
lectin, galactose binding, soluble 1 |
chr15_-_89310060 | 17.47 |
ENSMUST00000109313.9
|
Cpt1b
|
carnitine palmitoyltransferase 1b, muscle |
chr8_+_57964921 | 17.39 |
ENSMUST00000067925.8
|
Hmgb2
|
high mobility group box 2 |
chr6_-_7693184 | 17.34 |
ENSMUST00000031766.12
|
Asns
|
asparagine synthetase |
chr7_+_27147475 | 17.34 |
ENSMUST00000133750.8
|
Blvrb
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr1_-_71142305 | 17.33 |
ENSMUST00000027393.8
|
Bard1
|
BRCA1 associated RING domain 1 |
chr3_-_127689890 | 17.32 |
ENSMUST00000057198.9
ENSMUST00000199273.2 |
Fam241a
|
family with sequence similarity 241, member A |
chr11_+_117740077 | 17.21 |
ENSMUST00000081387.11
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr3_+_10077608 | 17.20 |
ENSMUST00000029046.9
|
Fabp5
|
fatty acid binding protein 5, epidermal |
chr12_+_112611069 | 17.16 |
ENSMUST00000021728.12
|
Siva1
|
SIVA1, apoptosis-inducing factor |
chr11_+_94900677 | 17.15 |
ENSMUST00000055947.10
|
Samd14
|
sterile alpha motif domain containing 14 |
chr2_-_25911544 | 17.12 |
ENSMUST00000136750.3
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr6_-_86646118 | 17.07 |
ENSMUST00000001184.10
|
Mxd1
|
MAX dimerization protein 1 |
chr13_-_100922910 | 17.07 |
ENSMUST00000174038.2
ENSMUST00000091295.14 ENSMUST00000072119.15 |
Ccnb1
|
cyclin B1 |
chr6_-_125168637 | 17.01 |
ENSMUST00000043848.11
|
Ncapd2
|
non-SMC condensin I complex, subunit D2 |
chr8_-_122634418 | 16.99 |
ENSMUST00000045557.10
|
Slc7a5
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
chr5_-_129085558 | 16.90 |
ENSMUST00000100680.10
|
Stx2
|
syntaxin 2 |
chr2_+_84669739 | 16.83 |
ENSMUST00000146816.8
ENSMUST00000028469.14 |
Slc43a1
|
solute carrier family 43, member 1 |
chr9_-_21202545 | 16.81 |
ENSMUST00000215619.2
|
Cdkn2d
|
cyclin dependent kinase inhibitor 2D |
chr5_-_24235646 | 16.70 |
ENSMUST00000197617.5
ENSMUST00000030849.13 |
Fam126a
|
family with sequence similarity 126, member A |
chr1_-_180641159 | 16.68 |
ENSMUST00000162118.8
ENSMUST00000159685.2 ENSMUST00000161308.8 |
H3f3a
|
H3.3 histone A |
chr11_-_70146156 | 16.66 |
ENSMUST00000108574.3
ENSMUST00000000329.9 |
Alox12
|
arachidonate 12-lipoxygenase |
chr17_-_26420300 | 16.66 |
ENSMUST00000025019.9
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr5_-_115439016 | 16.59 |
ENSMUST00000009157.4
|
Dynll1
|
dynein light chain LC8-type 1 |
chr7_-_142213219 | 16.57 |
ENSMUST00000121128.8
|
Igf2
|
insulin-like growth factor 2 |
chr16_+_32427738 | 16.40 |
ENSMUST00000023486.15
|
Tfrc
|
transferrin receptor |
chr11_+_72851989 | 16.35 |
ENSMUST00000163326.8
ENSMUST00000108485.9 ENSMUST00000021142.8 ENSMUST00000108486.8 ENSMUST00000108484.8 |
Atp2a3
|
ATPase, Ca++ transporting, ubiquitous |
chr13_+_55593116 | 16.18 |
ENSMUST00000001115.16
ENSMUST00000224995.2 ENSMUST00000225925.2 ENSMUST00000099482.5 ENSMUST00000224118.2 |
Grk6
|
G protein-coupled receptor kinase 6 |
chr16_-_36228798 | 16.18 |
ENSMUST00000023619.8
|
Stfa2
|
stefin A2 |
chr2_+_119449192 | 16.13 |
ENSMUST00000028771.8
|
Nusap1
|
nucleolar and spindle associated protein 1 |
chr7_-_44198157 | 16.07 |
ENSMUST00000145956.2
ENSMUST00000049343.15 |
Pold1
|
polymerase (DNA directed), delta 1, catalytic subunit |
chr5_-_115438971 | 16.04 |
ENSMUST00000112090.2
|
Dynll1
|
dynein light chain LC8-type 1 |
chr6_-_39396902 | 15.98 |
ENSMUST00000122996.8
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr8_-_95602952 | 15.90 |
ENSMUST00000046461.9
|
Dok4
|
docking protein 4 |
chr10_+_79824418 | 15.88 |
ENSMUST00000004784.11
ENSMUST00000105374.2 |
Cnn2
|
calponin 2 |
chr7_-_143056252 | 15.88 |
ENSMUST00000010904.5
|
Phlda2
|
pleckstrin homology like domain, family A, member 2 |
chr3_-_90603013 | 15.78 |
ENSMUST00000069960.12
ENSMUST00000117167.2 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr12_+_113115632 | 15.63 |
ENSMUST00000006523.12
ENSMUST00000200553.2 |
Crip1
|
cysteine-rich protein 1 (intestinal) |
chr2_+_131333800 | 15.60 |
ENSMUST00000110179.9
ENSMUST00000110189.9 ENSMUST00000110182.9 ENSMUST00000110183.9 ENSMUST00000110186.9 ENSMUST00000110188.8 |
Smox
|
spermine oxidase |
chr13_+_45660905 | 15.54 |
ENSMUST00000000260.13
|
Gmpr
|
guanosine monophosphate reductase |
chr10_+_43455919 | 15.52 |
ENSMUST00000214476.2
|
Cd24a
|
CD24a antigen |
chr11_-_4544751 | 15.48 |
ENSMUST00000109943.10
|
Mtmr3
|
myotubularin related protein 3 |
chr8_+_117648474 | 15.27 |
ENSMUST00000034205.5
ENSMUST00000212775.2 |
Cenpn
|
centromere protein N |
chrX_-_149595873 | 15.26 |
ENSMUST00000131241.2
ENSMUST00000147152.3 ENSMUST00000143843.8 |
Maged2
|
MAGE family member D2 |
chr18_-_42084249 | 15.14 |
ENSMUST00000070949.6
ENSMUST00000235606.2 |
Prelid2
|
PRELI domain containing 2 |
chr8_+_86026261 | 15.07 |
ENSMUST00000211597.2
ENSMUST00000211396.2 |
Orc6
|
origin recognition complex, subunit 6 |
chr11_-_11987391 | 15.02 |
ENSMUST00000093321.12
|
Grb10
|
growth factor receptor bound protein 10 |
chr14_-_67953035 | 14.86 |
ENSMUST00000163100.8
ENSMUST00000132705.8 ENSMUST00000124045.3 |
Cdca2
|
cell division cycle associated 2 |
chr10_+_79762858 | 14.81 |
ENSMUST00000019708.12
ENSMUST00000105377.8 |
Arid3a
|
AT rich interactive domain 3A (BRIGHT-like) |
chr4_+_44300876 | 14.79 |
ENSMUST00000045607.12
|
Melk
|
maternal embryonic leucine zipper kinase |
chr17_-_7050145 | 14.78 |
ENSMUST00000064234.7
|
Ezr
|
ezrin |
chr13_+_73615316 | 14.74 |
ENSMUST00000022099.15
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1 |
chr19_-_5323092 | 14.64 |
ENSMUST00000237463.2
ENSMUST00000025786.9 |
Pacs1
|
phosphofurin acidic cluster sorting protein 1 |
chr15_-_81845050 | 14.60 |
ENSMUST00000071462.7
ENSMUST00000023112.12 |
Pmm1
|
phosphomannomutase 1 |
chr6_-_7692855 | 14.60 |
ENSMUST00000115542.8
ENSMUST00000148349.2 |
Asns
|
asparagine synthetase |
chr6_-_88875646 | 14.51 |
ENSMUST00000058011.8
|
Mcm2
|
minichromosome maintenance complex component 2 |
chr6_-_83294526 | 14.50 |
ENSMUST00000005810.9
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
chr5_-_129085610 | 14.46 |
ENSMUST00000031378.14
|
Stx2
|
syntaxin 2 |
chr5_-_139722046 | 14.46 |
ENSMUST00000044642.14
|
Micall2
|
MICAL-like 2 |
chr15_+_76131020 | 14.45 |
ENSMUST00000229380.2
|
Grina
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
chr8_+_57964956 | 14.39 |
ENSMUST00000210871.2
|
Hmgb2
|
high mobility group box 2 |
chr4_-_154110494 | 14.37 |
ENSMUST00000131325.3
ENSMUST00000146054.8 ENSMUST00000126119.8 ENSMUST00000125533.9 |
Smim1
|
small integral membrane protein 1 |
chr7_+_99184645 | 14.35 |
ENSMUST00000098266.9
ENSMUST00000179755.8 |
Arrb1
|
arrestin, beta 1 |
chr2_+_32477069 | 14.33 |
ENSMUST00000102818.11
|
St6galnac4
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
chr1_-_131066004 | 14.27 |
ENSMUST00000016670.9
|
Dyrk3
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
chr10_+_79716876 | 14.24 |
ENSMUST00000166201.2
|
Prtn3
|
proteinase 3 |
chr9_-_21202693 | 14.20 |
ENSMUST00000213407.2
|
Cdkn2d
|
cyclin dependent kinase inhibitor 2D |
chrX_-_138772383 | 14.19 |
ENSMUST00000033811.14
ENSMUST00000087401.12 |
Morc4
|
microrchidia 4 |
chr2_+_172863688 | 14.18 |
ENSMUST00000029014.16
|
Rbm38
|
RNA binding motif protein 38 |
chr9_-_114610879 | 14.13 |
ENSMUST00000084867.9
ENSMUST00000216760.2 ENSMUST00000035009.16 |
Cmtm7
|
CKLF-like MARVEL transmembrane domain containing 7 |
chr9_-_21829385 | 14.13 |
ENSMUST00000128442.2
ENSMUST00000119055.8 ENSMUST00000122211.8 ENSMUST00000115351.10 |
Rab3d
|
RAB3D, member RAS oncogene family |
chr14_-_70873385 | 14.09 |
ENSMUST00000228295.2
ENSMUST00000022695.16 |
Dmtn
|
dematin actin binding protein |
chr15_+_82225380 | 14.06 |
ENSMUST00000050349.3
|
Pheta2
|
PH domain containing endocytic trafficking adaptor 2 |
chr11_+_117740111 | 14.04 |
ENSMUST00000093906.5
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr7_+_79309938 | 14.01 |
ENSMUST00000035977.9
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr5_+_143608194 | 13.98 |
ENSMUST00000116456.10
|
Cyth3
|
cytohesin 3 |
chr1_-_180641099 | 13.93 |
ENSMUST00000159789.2
ENSMUST00000081026.11 |
H3f3a
|
H3.3 histone A |
chr10_-_80537652 | 13.90 |
ENSMUST00000003438.11
|
Mob3a
|
MOB kinase activator 3A |
chr9_+_50768224 | 13.83 |
ENSMUST00000174628.8
ENSMUST00000034560.14 ENSMUST00000114437.9 ENSMUST00000175645.8 ENSMUST00000176349.8 ENSMUST00000176798.8 ENSMUST00000175640.8 |
Ppp2r1b
|
protein phosphatase 2, regulatory subunit A, beta |
chr4_+_52439237 | 13.80 |
ENSMUST00000102915.10
ENSMUST00000117280.8 ENSMUST00000142227.3 |
Smc2
|
structural maintenance of chromosomes 2 |
chr4_-_152561896 | 13.76 |
ENSMUST00000238738.2
ENSMUST00000162017.3 ENSMUST00000030768.10 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr16_+_93680783 | 13.75 |
ENSMUST00000023666.11
ENSMUST00000117099.8 |
Chaf1b
|
chromatin assembly factor 1, subunit B (p60) |
chrX_-_135116192 | 13.62 |
ENSMUST00000113120.2
ENSMUST00000113118.2 ENSMUST00000058125.9 |
Bex1
|
brain expressed X-linked 1 |
chr3_+_68912302 | 13.62 |
ENSMUST00000136502.8
ENSMUST00000107803.7 |
Smc4
|
structural maintenance of chromosomes 4 |
chr5_-_140634773 | 13.61 |
ENSMUST00000197452.5
ENSMUST00000042661.8 |
Ttyh3
|
tweety family member 3 |
chr17_-_6367692 | 13.59 |
ENSMUST00000232499.2
ENSMUST00000169415.3 |
Dynlt1a
|
dynein light chain Tctex-type 1A |
chr9_-_66826928 | 13.58 |
ENSMUST00000041139.9
|
Rab8b
|
RAB8B, member RAS oncogene family |
chr3_+_108291145 | 13.57 |
ENSMUST00000090561.10
ENSMUST00000102629.8 ENSMUST00000128089.2 |
Psrc1
|
proline/serine-rich coiled-coil 1 |
chr12_+_32428691 | 13.52 |
ENSMUST00000172332.4
|
Ccdc71l
|
coiled-coil domain containing 71 like |
chr13_-_55477535 | 13.49 |
ENSMUST00000021941.8
|
Mxd3
|
Max dimerization protein 3 |
chr13_+_35925296 | 13.46 |
ENSMUST00000163595.3
|
Cdyl
|
chromodomain protein, Y chromosome-like |
chr1_-_180641430 | 13.40 |
ENSMUST00000162814.8
|
H3f3a
|
H3.3 histone A |
chr8_-_54091980 | 13.40 |
ENSMUST00000047768.11
|
Neil3
|
nei like 3 (E. coli) |
chr13_+_117356808 | 13.36 |
ENSMUST00000022242.9
|
Emb
|
embigin |
chr7_-_30234422 | 13.35 |
ENSMUST00000208522.2
ENSMUST00000207860.2 ENSMUST00000208538.2 |
Arhgap33
|
Rho GTPase activating protein 33 |
chr8_+_95703728 | 13.29 |
ENSMUST00000179619.9
|
Adgrg1
|
adhesion G protein-coupled receptor G1 |
chr9_+_59563838 | 13.28 |
ENSMUST00000163694.4
|
Pkm
|
pyruvate kinase, muscle |
chr15_-_36609208 | 13.15 |
ENSMUST00000001809.15
|
Pabpc1
|
poly(A) binding protein, cytoplasmic 1 |
chr1_-_59012579 | 13.07 |
ENSMUST00000173590.2
ENSMUST00000027186.12 |
Trak2
|
trafficking protein, kinesin binding 2 |
chr18_+_50112494 | 13.03 |
ENSMUST00000148989.3
|
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr12_-_112792971 | 13.03 |
ENSMUST00000062092.7
ENSMUST00000220899.2 |
Cdca4
|
cell division cycle associated 4 |
chr4_+_134195631 | 12.94 |
ENSMUST00000030636.11
ENSMUST00000127279.8 ENSMUST00000105867.8 |
Stmn1
|
stathmin 1 |
chr2_+_158610003 | 12.92 |
ENSMUST00000029183.3
|
Fam83d
|
family with sequence similarity 83, member D |
chr4_+_114914607 | 12.91 |
ENSMUST00000136946.8
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr17_+_36172235 | 12.87 |
ENSMUST00000172931.2
|
Nrm
|
nurim (nuclear envelope membrane protein) |
chr4_+_119052476 | 12.83 |
ENSMUST00000030395.9
|
Svbp
|
small vasohibin binding protein |
chr17_-_46940346 | 12.80 |
ENSMUST00000044442.10
|
Ptk7
|
PTK7 protein tyrosine kinase 7 |
chr4_+_124594492 | 12.78 |
ENSMUST00000106199.10
ENSMUST00000038684.6 |
Fhl3
|
four and a half LIM domains 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 44.7 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
14.5 | 43.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
11.4 | 45.4 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
11.3 | 34.0 | GO:0030221 | basophil differentiation(GO:0030221) |
11.0 | 33.0 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
10.7 | 53.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
10.4 | 62.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
9.9 | 29.8 | GO:0015825 | L-serine transport(GO:0015825) |
9.6 | 28.9 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
8.8 | 44.0 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
8.7 | 26.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
8.6 | 25.8 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
8.0 | 96.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
8.0 | 55.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
7.9 | 23.6 | GO:0045004 | DNA replication proofreading(GO:0045004) |
7.8 | 31.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
7.5 | 30.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
7.3 | 73.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
7.1 | 21.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
6.9 | 34.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
6.6 | 26.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
6.6 | 26.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
6.5 | 19.4 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
6.3 | 18.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
6.3 | 25.0 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
6.1 | 18.2 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
6.0 | 42.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
6.0 | 24.0 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
5.9 | 23.6 | GO:0036233 | glycine import(GO:0036233) |
5.9 | 17.7 | GO:0010925 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) protein secretion by platelet(GO:0070560) |
5.8 | 29.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
5.8 | 23.2 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
5.8 | 28.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
5.7 | 28.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
5.7 | 62.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
5.7 | 51.0 | GO:0007144 | female meiosis I(GO:0007144) |
5.7 | 22.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
5.6 | 28.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
5.6 | 27.9 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
5.4 | 21.4 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
5.3 | 21.3 | GO:0010286 | heat acclimation(GO:0010286) |
5.3 | 42.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
5.2 | 20.8 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
5.2 | 15.5 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
5.1 | 15.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
5.0 | 20.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
5.0 | 14.9 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
5.0 | 24.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
5.0 | 29.8 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
4.9 | 19.6 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
4.9 | 19.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
4.8 | 28.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
4.8 | 4.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
4.8 | 14.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
4.7 | 51.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
4.7 | 93.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
4.6 | 13.9 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
4.6 | 45.6 | GO:0048102 | autophagic cell death(GO:0048102) |
4.5 | 18.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
4.5 | 9.1 | GO:0097017 | renal protein absorption(GO:0097017) |
4.5 | 36.0 | GO:0032796 | uropod organization(GO:0032796) |
4.4 | 8.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
4.4 | 26.2 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
4.4 | 39.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
4.4 | 39.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
4.3 | 30.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
4.3 | 25.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
4.2 | 12.7 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
4.2 | 185.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
4.2 | 33.7 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
4.2 | 16.8 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
4.2 | 20.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
4.1 | 12.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.0 | 20.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
4.0 | 20.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
4.0 | 4.0 | GO:0001966 | thigmotaxis(GO:0001966) |
4.0 | 4.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
3.9 | 7.9 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
3.9 | 19.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
3.9 | 42.8 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
3.9 | 15.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
3.9 | 23.2 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
3.8 | 19.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
3.8 | 18.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.8 | 22.5 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
3.8 | 11.3 | GO:0015793 | glycerol transport(GO:0015793) |
3.8 | 15.0 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
3.7 | 56.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
3.7 | 22.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
3.7 | 11.1 | GO:0002215 | defense response to nematode(GO:0002215) |
3.7 | 14.7 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
3.7 | 3.7 | GO:0048254 | snoRNA localization(GO:0048254) |
3.7 | 3.7 | GO:0097324 | melanocyte migration(GO:0097324) |
3.6 | 14.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
3.6 | 35.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
3.6 | 10.7 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
3.6 | 28.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
3.5 | 10.6 | GO:0098749 | cerebellar neuron development(GO:0098749) |
3.5 | 52.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
3.5 | 34.9 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
3.5 | 17.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
3.4 | 13.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
3.4 | 17.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
3.4 | 10.3 | GO:1990428 | miRNA transport(GO:1990428) |
3.4 | 40.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
3.3 | 13.3 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
3.3 | 10.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
3.3 | 16.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
3.3 | 9.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
3.2 | 25.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
3.2 | 9.7 | GO:0014737 | positive regulation of muscle atrophy(GO:0014737) |
3.2 | 19.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
3.2 | 16.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
3.2 | 22.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
3.2 | 12.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
3.2 | 25.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
3.2 | 47.8 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
3.2 | 31.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
3.2 | 28.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
3.1 | 28.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
3.1 | 9.4 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
3.1 | 15.7 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
3.1 | 9.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
3.1 | 9.3 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
3.1 | 6.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
3.1 | 15.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
3.1 | 24.5 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
3.1 | 9.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
3.0 | 12.2 | GO:0015904 | tetracycline transport(GO:0015904) |
3.0 | 9.1 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
3.0 | 3.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
3.0 | 51.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
3.0 | 8.9 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.9 | 8.8 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
2.9 | 26.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.9 | 5.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
2.9 | 20.0 | GO:0051697 | protein delipidation(GO:0051697) |
2.8 | 14.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.8 | 22.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
2.8 | 42.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
2.8 | 11.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
2.8 | 11.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
2.8 | 19.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
2.8 | 11.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
2.8 | 35.8 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
2.7 | 13.7 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
2.7 | 2.7 | GO:0035844 | cloaca development(GO:0035844) |
2.7 | 8.1 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
2.7 | 10.8 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
2.7 | 21.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.7 | 16.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
2.6 | 23.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.6 | 7.9 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.6 | 7.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
2.6 | 5.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
2.6 | 7.8 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
2.6 | 25.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
2.6 | 15.5 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.6 | 15.4 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
2.5 | 7.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
2.5 | 17.6 | GO:0021592 | fourth ventricle development(GO:0021592) |
2.5 | 10.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
2.5 | 14.9 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
2.5 | 7.4 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
2.5 | 14.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.4 | 78.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
2.4 | 12.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
2.4 | 19.3 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.4 | 9.5 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
2.4 | 16.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.3 | 14.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
2.3 | 11.7 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
2.3 | 18.7 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
2.3 | 14.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
2.3 | 9.3 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
2.3 | 20.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
2.3 | 9.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
2.3 | 6.9 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
2.3 | 11.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
2.3 | 15.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.3 | 25.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.3 | 2.3 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
2.3 | 52.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
2.2 | 4.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
2.2 | 6.7 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
2.2 | 6.7 | GO:0035934 | corticosterone secretion(GO:0035934) |
2.2 | 24.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.2 | 17.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.2 | 26.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
2.2 | 2.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.2 | 2.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
2.2 | 13.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.2 | 6.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
2.2 | 15.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
2.2 | 11.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.2 | 6.6 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
2.2 | 6.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
2.2 | 4.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.2 | 12.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.2 | 4.3 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
2.1 | 30.0 | GO:0015816 | glycine transport(GO:0015816) |
2.1 | 12.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.1 | 6.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
2.1 | 10.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
2.1 | 10.6 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
2.1 | 8.5 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.1 | 6.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
2.1 | 29.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.1 | 35.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
2.1 | 4.2 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
2.1 | 8.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
2.1 | 4.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
2.1 | 10.4 | GO:1901563 | response to camptothecin(GO:1901563) |
2.1 | 41.4 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
2.1 | 12.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.1 | 2.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
2.1 | 30.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.1 | 2.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
2.0 | 12.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
2.0 | 12.2 | GO:0015871 | choline transport(GO:0015871) |
2.0 | 26.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.0 | 8.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.0 | 8.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
2.0 | 12.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
2.0 | 14.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
2.0 | 3.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.0 | 2.0 | GO:1904464 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
2.0 | 5.9 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
1.9 | 3.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.9 | 27.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.9 | 5.8 | GO:0048478 | replication fork protection(GO:0048478) |
1.9 | 15.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.9 | 15.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.9 | 7.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
1.9 | 1.9 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
1.9 | 3.8 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
1.9 | 7.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.9 | 1.9 | GO:2000424 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
1.9 | 26.4 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.9 | 5.6 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
1.9 | 7.5 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
1.9 | 5.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.9 | 11.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.9 | 5.6 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
1.9 | 5.6 | GO:0070839 | divalent metal ion export(GO:0070839) |
1.9 | 5.6 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
1.8 | 44.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.8 | 14.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.8 | 3.6 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
1.8 | 5.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
1.8 | 3.6 | GO:0017126 | nucleologenesis(GO:0017126) |
1.8 | 7.2 | GO:0030421 | defecation(GO:0030421) |
1.8 | 1.8 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.8 | 3.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.8 | 1.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.8 | 7.0 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
1.8 | 1.8 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.7 | 7.0 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.7 | 5.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.7 | 3.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.7 | 5.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.7 | 5.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.7 | 11.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.7 | 3.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.7 | 6.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.7 | 8.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.7 | 15.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.7 | 5.0 | GO:0035425 | autocrine signaling(GO:0035425) |
1.7 | 10.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.7 | 8.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.7 | 1.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.7 | 6.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.7 | 24.8 | GO:0006241 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
1.6 | 6.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.6 | 3.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.6 | 1.6 | GO:0061511 | centriole elongation(GO:0061511) |
1.6 | 6.5 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
1.6 | 4.9 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.6 | 14.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.6 | 1.6 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
1.6 | 1.6 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
1.6 | 3.2 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.6 | 1.6 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
1.6 | 8.1 | GO:0009597 | detection of virus(GO:0009597) |
1.6 | 6.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.6 | 22.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.6 | 9.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.6 | 4.8 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.6 | 6.3 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
1.6 | 30.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
1.6 | 1.6 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
1.6 | 6.3 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
1.6 | 1.6 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.6 | 4.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.6 | 4.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.6 | 1.6 | GO:0051595 | response to methylglyoxal(GO:0051595) |
1.6 | 20.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.6 | 17.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.6 | 1.6 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
1.6 | 4.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.6 | 21.7 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.5 | 54.1 | GO:0051225 | spindle assembly(GO:0051225) |
1.5 | 6.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.5 | 12.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.5 | 12.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.5 | 4.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.5 | 6.2 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
1.5 | 1.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.5 | 16.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.5 | 21.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.5 | 6.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.5 | 10.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.5 | 4.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.5 | 9.0 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
1.5 | 4.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 3.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
1.5 | 71.3 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
1.5 | 11.9 | GO:0044351 | macropinocytosis(GO:0044351) |
1.5 | 8.9 | GO:0044838 | cell quiescence(GO:0044838) |
1.5 | 1.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.5 | 5.9 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
1.5 | 26.6 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
1.5 | 4.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.5 | 4.4 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
1.5 | 1.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.5 | 7.3 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.4 | 5.8 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
1.4 | 43.4 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
1.4 | 2.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.4 | 11.5 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.4 | 17.3 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
1.4 | 2.9 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
1.4 | 4.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.4 | 8.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.4 | 2.8 | GO:0051031 | tRNA transport(GO:0051031) |
1.4 | 5.7 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
1.4 | 4.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
1.4 | 8.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.4 | 36.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.4 | 8.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.4 | 5.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.4 | 2.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.4 | 6.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
1.4 | 37.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.4 | 5.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
1.4 | 4.1 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
1.4 | 1.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.4 | 4.1 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
1.4 | 6.8 | GO:0030576 | Cajal body organization(GO:0030576) |
1.3 | 12.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.3 | 8.0 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.3 | 6.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
1.3 | 20.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.3 | 2.7 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.3 | 50.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.3 | 2.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
1.3 | 8.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.3 | 2.6 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.3 | 41.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.3 | 3.9 | GO:0036245 | cellular response to menadione(GO:0036245) |
1.3 | 6.5 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
1.3 | 55.9 | GO:0006284 | base-excision repair(GO:0006284) |
1.3 | 5.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.3 | 9.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.3 | 2.6 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
1.3 | 1.3 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.3 | 7.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.3 | 1.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.3 | 11.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.3 | 29.0 | GO:0001675 | acrosome assembly(GO:0001675) |
1.3 | 5.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.3 | 7.5 | GO:0007412 | axon target recognition(GO:0007412) |
1.3 | 2.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.3 | 20.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
1.2 | 1.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.2 | 31.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
1.2 | 3.7 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
1.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
1.2 | 6.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.2 | 4.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
1.2 | 4.9 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
1.2 | 7.3 | GO:0015671 | oxygen transport(GO:0015671) |
1.2 | 2.4 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
1.2 | 3.6 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
1.2 | 2.4 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.2 | 1.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.2 | 18.0 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
1.2 | 11.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.2 | 7.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
1.2 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.2 | 3.5 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.2 | 8.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.2 | 9.4 | GO:0015675 | nickel cation transport(GO:0015675) |
1.2 | 4.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.2 | 29.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.2 | 3.5 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
1.2 | 3.5 | GO:1902946 | protein localization to early endosome(GO:1902946) |
1.2 | 3.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.1 | 12.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.1 | 1.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.1 | 3.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
1.1 | 17.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.1 | 4.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.1 | 31.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
1.1 | 1.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.1 | 10.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.1 | 10.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.1 | 25.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.1 | 3.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.1 | 1.1 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
1.1 | 3.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.1 | 11.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.1 | 1.1 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
1.1 | 3.3 | GO:0051794 | regulation of catagen(GO:0051794) |
1.1 | 6.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.1 | 12.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
1.1 | 6.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.1 | 4.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.1 | 2.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
1.1 | 4.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.1 | 2.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
1.1 | 1.1 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
1.1 | 7.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.1 | 5.4 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
1.1 | 1.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.1 | 19.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.1 | 22.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.1 | 11.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
1.1 | 2.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
1.1 | 4.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
1.1 | 5.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
1.1 | 4.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.1 | 1.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.1 | 3.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.1 | 7.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.1 | 2.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.0 | 9.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
1.0 | 5.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.0 | 11.5 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
1.0 | 4.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
1.0 | 2.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.0 | 5.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.0 | 25.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
1.0 | 1.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.0 | 6.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.0 | 5.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.0 | 4.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.0 | 4.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
1.0 | 16.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 2.0 | GO:0072716 | response to actinomycin D(GO:0072716) |
1.0 | 2.0 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
1.0 | 5.1 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
1.0 | 8.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.0 | 8.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 2.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.0 | 2.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.0 | 3.0 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.0 | 1.0 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
1.0 | 2.0 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
1.0 | 3.0 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.0 | 14.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
1.0 | 16.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.0 | 23.9 | GO:0031100 | organ regeneration(GO:0031100) |
1.0 | 10.0 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.0 | 54.8 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
1.0 | 7.0 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.0 | 2.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.0 | 1.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.0 | 24.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.0 | 2.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.0 | 6.9 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.0 | 18.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.0 | 3.0 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.0 | 31.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.0 | 3.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.0 | 5.8 | GO:0006972 | hyperosmotic response(GO:0006972) |
1.0 | 4.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.0 | 23.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
1.0 | 4.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.0 | 1.0 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.0 | 63.3 | GO:0070527 | platelet aggregation(GO:0070527) |
1.0 | 3.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.0 | 23.8 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
1.0 | 3.8 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.9 | 31.3 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.9 | 2.8 | GO:0034164 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.9 | 0.9 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.9 | 1.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.9 | 9.4 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.9 | 1.9 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.9 | 3.8 | GO:0015846 | polyamine transport(GO:0015846) |
0.9 | 5.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.9 | 9.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.9 | 2.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.9 | 2.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.9 | 24.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.9 | 27.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.9 | 2.8 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.9 | 17.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.9 | 3.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.9 | 5.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.9 | 17.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.9 | 11.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.9 | 14.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.9 | 2.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.9 | 8.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.9 | 7.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.9 | 10.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.9 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 6.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.9 | 3.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 3.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.9 | 5.4 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.9 | 2.7 | GO:0097278 | transforming growth factor beta activation(GO:0036363) complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.9 | 2.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.9 | 3.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.9 | 0.9 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.9 | 7.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.9 | 3.5 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.9 | 6.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.9 | 7.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.9 | 34.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.9 | 26.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.9 | 7.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.9 | 5.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.9 | 1.7 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.9 | 2.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.9 | 1.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 2.6 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.9 | 6.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.8 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.8 | 6.8 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.8 | 0.8 | GO:0090135 | actin filament branching(GO:0090135) |
0.8 | 18.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.8 | 2.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.8 | 3.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.8 | 3.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.8 | 6.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.8 | 3.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.8 | 10.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.8 | 1.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.8 | 5.7 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.8 | 4.9 | GO:0090672 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) |
0.8 | 1.6 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.8 | 4.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.8 | 4.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.8 | 1.6 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.8 | 2.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.8 | 4.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.8 | 6.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.8 | 8.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.8 | 0.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.8 | 5.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.8 | 4.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.8 | 9.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.8 | 0.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.8 | 1.6 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.8 | 2.4 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.8 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.8 | 6.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.8 | 3.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.8 | 3.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 3.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.8 | 6.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.8 | 3.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.8 | 1.5 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.8 | 0.8 | GO:0018158 | protein oxidation(GO:0018158) |
0.8 | 0.8 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.8 | 4.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.8 | 4.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.8 | 0.8 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.8 | 8.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.7 | 10.5 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.7 | 2.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.7 | 3.0 | GO:0003017 | lymph circulation(GO:0003017) |
0.7 | 1.5 | GO:0021764 | amygdala development(GO:0021764) |
0.7 | 11.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.7 | 3.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 2.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.7 | 2.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.7 | 8.1 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 4.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.7 | 2.9 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.7 | 2.9 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.7 | 13.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.7 | 8.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 5.8 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) positive regulation of macrophage cytokine production(GO:0060907) |
0.7 | 0.7 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.7 | 2.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.7 | 5.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.7 | 4.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 14.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.7 | 2.1 | GO:0032262 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
0.7 | 5.7 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.7 | 4.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.7 | 2.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.7 | 1.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 6.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.7 | 3.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.7 | 0.7 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.7 | 0.7 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.7 | 4.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.7 | 24.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.7 | 1.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.7 | 2.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 2.8 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.7 | 3.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.7 | 10.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.7 | 4.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 2.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.7 | 4.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.7 | 2.0 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.7 | 2.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.7 | 19.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.7 | 1.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.7 | 2.0 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.7 | 8.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 1.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.7 | 3.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.7 | 36.8 | GO:0006414 | translational elongation(GO:0006414) |
0.7 | 17.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.7 | 0.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.7 | 2.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.7 | 0.7 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.7 | 15.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.7 | 6.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.6 | 0.6 | GO:0006113 | fermentation(GO:0006113) |
0.6 | 1.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 1.3 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
0.6 | 5.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 5.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.6 | 1.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.6 | 38.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.6 | 2.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 5.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 6.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.6 | 1.9 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.6 | 10.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.6 | 6.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.6 | 1.9 | GO:0055130 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.6 | 3.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 1.2 | GO:0060032 | notochord regression(GO:0060032) |
0.6 | 3.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 12.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 1.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.6 | 1.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.6 | 8.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 1.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 4.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 10.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 1.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.6 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 3.0 | GO:1900150 | antifungal innate immune response(GO:0061760) regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.6 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 5.8 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.6 | 7.6 | GO:0007099 | centriole replication(GO:0007099) |
0.6 | 2.9 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.6 | 2.3 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.6 | 30.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.6 | 4.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 1.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.6 | 1.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.6 | 7.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.6 | 2.3 | GO:0044805 | late nucleophagy(GO:0044805) |
0.6 | 0.6 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.6 | 6.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.6 | 1.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 10.8 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.6 | 1.7 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.6 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.6 | 2.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 2.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.6 | 5.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 5.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.6 | 2.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.6 | 10.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.6 | 17.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 10.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.6 | 7.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.6 | 1.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 2.2 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.6 | 1.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.6 | 3.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 23.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.5 | 17.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 2.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 2.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 10.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.5 | 1.6 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.5 | 0.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.5 | 3.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 1.6 | GO:0071846 | actin filament debranching(GO:0071846) |
0.5 | 7.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 30.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 3.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 0.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 1.6 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.5 | 1.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.5 | 7.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.5 | 1.6 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.5 | 1.6 | GO:0033189 | response to vitamin A(GO:0033189) |
0.5 | 15.3 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.5 | 4.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.5 | 4.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.5 | 3.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.5 | 1.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 4.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 7.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.5 | 0.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.5 | 2.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 3.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 48.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.5 | 0.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 1.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 3.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 2.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.5 | 4.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 8.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 0.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.5 | 5.5 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.5 | 0.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.5 | 3.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.5 | 1.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 2.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 7.8 | GO:0072010 | glomerular epithelium development(GO:0072010) |
0.5 | 13.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 1.9 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.5 | 0.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 0.5 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.5 | 3.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 1.0 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.5 | 0.5 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 19.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.5 | 7.1 | GO:0007343 | egg activation(GO:0007343) |
0.5 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.5 | 0.5 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.5 | 0.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 2.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.5 | 1.4 | GO:0071649 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.5 | 2.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 0.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 8.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.4 | 2.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 0.4 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) multi-organism localization(GO:1902579) |
0.4 | 68.9 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.4 | 12.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 3.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.4 | 0.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 3.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 0.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 0.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.4 | 1.3 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.4 | 2.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 1.7 | GO:0007619 | courtship behavior(GO:0007619) |
0.4 | 3.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 1.3 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.4 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 2.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.4 | 0.8 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.4 | 6.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.4 | 11.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 25.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 4.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 6.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 0.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 3.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 1.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 2.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 12.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.4 | 2.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 1.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.4 | 4.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 2.4 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.4 | 2.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.4 | 3.7 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 14.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.4 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 2.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 1.2 | GO:0014889 | muscle atrophy(GO:0014889) |
0.4 | 2.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.6 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.4 | 3.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 6.3 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.4 | 2.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 7.0 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.4 | 9.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.2 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 6.9 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.4 | 1.9 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 23.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.4 | 1.5 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 3.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 3.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.4 | 1.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 1.1 | GO:1904266 | regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
0.4 | 10.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 3.0 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 4.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 8.6 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.4 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 1.5 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.4 | 2.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 5.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 10.2 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.4 | 5.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 2.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 1.1 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.4 | 2.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 0.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 1.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 1.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 6.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.4 | 0.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.4 | 2.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.4 | 1.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 1.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.3 | 2.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 2.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 1.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 1.4 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 1.0 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 2.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 1.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 5.7 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 8.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 2.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.3 | 10.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 1.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 2.3 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.3 | 1.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.3 | 1.3 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.3 | 1.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.3 | 1.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 15.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 17.8 | GO:0000910 | cytokinesis(GO:0000910) |
0.3 | 3.2 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.3 | 1.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 2.8 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 13.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 0.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 2.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 1.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 0.9 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.3 | 0.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.3 | 0.9 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.3 | 3.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 4.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 0.9 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.3 | 0.9 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 3.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 1.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.3 | 4.7 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.3 | 1.5 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.3 | 20.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.9 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 1.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.3 | 0.6 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.3 | 0.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 2.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 2.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 3.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 4.5 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.3 | 3.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 2.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.3 | 0.8 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.3 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 2.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.3 | 0.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.3 | 2.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 0.8 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.3 | 1.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 1.3 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.3 | 3.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 4.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 2.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 3.8 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.3 | 0.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 1.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.3 | 1.0 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.3 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 1.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 1.0 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 1.7 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 1.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 1.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.2 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.2 | 2.4 | GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) |
0.2 | 1.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.2 | 1.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 6.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 2.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 2.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 1.6 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 1.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.5 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.2 | 1.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 3.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 3.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 7.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 0.2 | GO:0002859 | negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.2 | 0.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 1.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 1.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 11.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 1.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 1.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.8 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 1.9 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 1.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 2.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 1.7 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) |
0.2 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 3.9 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.4 | GO:0009644 | response to high light intensity(GO:0009644) |
0.2 | 0.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.8 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.2 | 2.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 1.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.6 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.2 | 2.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 1.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 2.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 3.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 1.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.2 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 1.0 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.2 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 5.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 2.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 4.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.2 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) atrioventricular canal development(GO:0036302) |
0.2 | 1.5 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 3.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 2.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 3.9 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 0.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 1.3 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 3.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.5 | GO:0046032 | ADP catabolic process(GO:0046032) |
0.2 | 1.1 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 5.1 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 5.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.4 | GO:0042245 | RNA repair(GO:0042245) |
0.1 | 0.4 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.1 | 0.6 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 2.7 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.6 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.6 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 2.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 1.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 2.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.6 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 0.6 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.3 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.3 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.1 | 1.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.3 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 5.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 1.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 1.5 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 2.6 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.7 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 5.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.5 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 2.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 2.0 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.1 | 1.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 4.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 1.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 2.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 1.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.5 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 1.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 2.2 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 1.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 2.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 12.8 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.2 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 1.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.5 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 1.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 1.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 2.3 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 11.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.4 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.1 | 0.4 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 2.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.5 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.8 | GO:0042092 | type 2 immune response(GO:0042092) |
0.1 | 0.7 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 0.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.1 | 2.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 5.6 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 3.2 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 0.1 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 0.3 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.7 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 2.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.1 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.1 | 1.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.2 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 5.9 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:0072201 | mesenchymal cell proliferation involved in lung development(GO:0060916) negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.0 | 0.4 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 1.5 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 3.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 1.7 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.0 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.0 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0032725 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.0 | 0.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 44.7 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
13.0 | 38.9 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
12.4 | 49.6 | GO:0001740 | Barr body(GO:0001740) |
12.3 | 74.0 | GO:0031523 | Myb complex(GO:0031523) |
9.5 | 66.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
8.9 | 26.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
8.7 | 34.9 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
7.4 | 22.1 | GO:1990031 | pinceau fiber(GO:1990031) |
7.1 | 85.6 | GO:0000796 | condensin complex(GO:0000796) |
6.9 | 75.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
6.8 | 54.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
6.0 | 29.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
5.7 | 22.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
5.6 | 28.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
5.5 | 5.5 | GO:1902737 | dendritic filopodium(GO:1902737) |
5.4 | 16.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
5.0 | 39.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
4.8 | 14.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
4.8 | 14.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
4.8 | 19.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
4.7 | 9.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
4.4 | 26.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
4.1 | 32.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
4.1 | 28.7 | GO:0005638 | lamin filament(GO:0005638) |
3.9 | 31.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
3.9 | 19.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
3.8 | 22.5 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
3.7 | 54.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.6 | 10.9 | GO:0034455 | t-UTP complex(GO:0034455) |
3.5 | 21.0 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
3.4 | 107.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
3.3 | 56.2 | GO:0090543 | Flemming body(GO:0090543) |
3.2 | 12.8 | GO:0036284 | tubulobulbar complex(GO:0036284) |
3.2 | 15.9 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
3.1 | 9.4 | GO:0000811 | GINS complex(GO:0000811) |
2.9 | 14.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.9 | 8.7 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
2.9 | 8.6 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
2.9 | 14.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.8 | 36.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.8 | 24.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.8 | 8.3 | GO:0031904 | endosome lumen(GO:0031904) |
2.7 | 5.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.7 | 27.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
2.7 | 24.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.6 | 39.6 | GO:0042555 | MCM complex(GO:0042555) |
2.6 | 5.1 | GO:0042585 | germinal vesicle(GO:0042585) |
2.5 | 17.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
2.5 | 10.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
2.5 | 40.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.5 | 20.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
2.5 | 22.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
2.4 | 26.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
2.4 | 9.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
2.4 | 36.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.4 | 52.2 | GO:0042581 | specific granule(GO:0042581) |
2.4 | 7.1 | GO:0070985 | TFIIK complex(GO:0070985) |
2.3 | 39.6 | GO:0001939 | female pronucleus(GO:0001939) |
2.3 | 16.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
2.3 | 9.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.3 | 11.5 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
2.3 | 11.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
2.3 | 31.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
2.3 | 13.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
2.2 | 11.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.2 | 22.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.2 | 30.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
2.1 | 8.6 | GO:0034683 | integrin alphav-beta3 complex(GO:0034683) |
2.1 | 4.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.1 | 20.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
2.1 | 8.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
2.1 | 2.1 | GO:0019034 | viral replication complex(GO:0019034) |
2.1 | 6.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
2.1 | 14.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
2.1 | 41.1 | GO:0031143 | pseudopodium(GO:0031143) |
2.0 | 8.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.0 | 10.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.0 | 7.9 | GO:0014802 | terminal cisterna(GO:0014802) |
2.0 | 65.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.0 | 15.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
2.0 | 11.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.0 | 21.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
2.0 | 107.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.9 | 5.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.9 | 31.0 | GO:0005652 | nuclear lamina(GO:0005652) |
1.9 | 28.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.9 | 7.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.9 | 41.8 | GO:0031011 | Ino80 complex(GO:0031011) |
1.9 | 5.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.9 | 5.6 | GO:1990423 | RZZ complex(GO:1990423) |
1.9 | 22.5 | GO:0034709 | methylosome(GO:0034709) |
1.9 | 11.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.9 | 16.7 | GO:0070652 | HAUS complex(GO:0070652) |
1.9 | 18.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.8 | 5.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.8 | 45.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.8 | 5.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
1.8 | 19.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.8 | 3.6 | GO:0016342 | catenin complex(GO:0016342) |
1.8 | 7.1 | GO:0032021 | NELF complex(GO:0032021) |
1.8 | 16.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.8 | 3.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.7 | 98.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.7 | 15.6 | GO:0097427 | microtubule bundle(GO:0097427) |
1.7 | 6.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.7 | 8.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.7 | 3.4 | GO:0097470 | ribbon synapse(GO:0097470) |
1.7 | 135.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.6 | 29.5 | GO:0000346 | transcription export complex(GO:0000346) |
1.6 | 1.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.6 | 15.8 | GO:0042382 | paraspeckles(GO:0042382) |
1.6 | 15.7 | GO:0000812 | Swr1 complex(GO:0000812) |
1.6 | 7.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.5 | 15.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.5 | 20.7 | GO:0044327 | dendritic spine head(GO:0044327) |
1.5 | 16.1 | GO:0008278 | cohesin complex(GO:0008278) |
1.5 | 7.3 | GO:0045160 | myosin I complex(GO:0045160) |
1.4 | 15.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.4 | 31.3 | GO:0071564 | npBAF complex(GO:0071564) |
1.4 | 147.8 | GO:0000922 | spindle pole(GO:0000922) |
1.4 | 12.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.4 | 29.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.4 | 5.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.4 | 24.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.4 | 13.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.4 | 4.1 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
1.4 | 8.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.4 | 6.8 | GO:0033269 | internode region of axon(GO:0033269) |
1.4 | 12.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.3 | 33.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.3 | 4.0 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
1.3 | 3.9 | GO:1990879 | CST complex(GO:1990879) |
1.3 | 14.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.3 | 3.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
1.3 | 41.9 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 11.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.2 | 22.3 | GO:0010369 | chromocenter(GO:0010369) |
1.2 | 22.3 | GO:0036038 | MKS complex(GO:0036038) |
1.2 | 3.7 | GO:0005584 | collagen type I trimer(GO:0005584) |
1.2 | 20.8 | GO:0016600 | flotillin complex(GO:0016600) |
1.2 | 14.5 | GO:0016580 | Sin3 complex(GO:0016580) |
1.2 | 3.6 | GO:0090537 | CERF complex(GO:0090537) |
1.2 | 31.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.2 | 4.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.2 | 8.2 | GO:0036396 | MIS complex(GO:0036396) |
1.1 | 15.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.1 | 21.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.1 | 6.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.1 | 7.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 11.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.1 | 4.4 | GO:0071920 | cleavage body(GO:0071920) |
1.1 | 58.8 | GO:0005657 | replication fork(GO:0005657) |
1.1 | 46.3 | GO:0002102 | podosome(GO:0002102) |
1.1 | 7.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.1 | 7.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
1.1 | 6.3 | GO:0070449 | elongin complex(GO:0070449) |
1.0 | 3.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
1.0 | 34.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
1.0 | 7.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.0 | 7.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.0 | 5.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.0 | 26.4 | GO:0005876 | spindle microtubule(GO:0005876) |
1.0 | 13.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.9 | 17.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.9 | 13.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.9 | 27.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.9 | 16.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 3.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.9 | 5.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 79.7 | GO:0000776 | kinetochore(GO:0000776) |
0.9 | 4.5 | GO:0043293 | apoptosome(GO:0043293) |
0.9 | 6.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.9 | 10.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.9 | 38.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.9 | 10.5 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 10.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.9 | 2.6 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.9 | 51.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.9 | 1.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.9 | 90.9 | GO:0005819 | spindle(GO:0005819) |
0.9 | 15.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 5.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.8 | 1.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.8 | 8.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.8 | 14.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.8 | 9.1 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 7.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 6.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 1.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.8 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.8 | 17.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.8 | 6.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.8 | 56.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.8 | 23.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.8 | 4.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 12.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.8 | 18.2 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 12.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 3.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.8 | 83.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.8 | 1.5 | GO:0016589 | NURF complex(GO:0016589) |
0.8 | 6.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 8.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.8 | 0.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.8 | 2.3 | GO:0097635 | extrinsic component of pre-autophagosomal structure membrane(GO:0097632) extrinsic component of autophagosome membrane(GO:0097635) |
0.8 | 4.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 11.2 | GO:0051286 | cell tip(GO:0051286) |
0.7 | 5.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 31.0 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.7 | 83.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.7 | 102.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.7 | 7.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.7 | 3.6 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.7 | 2.1 | GO:0097144 | BAX complex(GO:0097144) |
0.7 | 2.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 6.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 60.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.7 | 4.0 | GO:0070826 | paraferritin complex(GO:0070826) |
0.7 | 5.3 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 7.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.7 | 7.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 5.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.6 | 70.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.6 | 1.9 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.6 | 1.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.6 | 3.2 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.6 | 2.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 1.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 23.9 | GO:0008305 | integrin complex(GO:0008305) |
0.6 | 3.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 16.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 7.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.6 | 1.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 39.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.6 | 2.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 14.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.6 | 15.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.6 | 28.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.6 | 2.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 8.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.6 | 17.8 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 14.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.5 | 5.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 29.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 33.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 1.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 23.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.5 | 17.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.5 | 4.1 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.5 | 1.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 0.5 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.5 | 4.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 1.5 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.5 | 2.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.5 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.5 | 4.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 2.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.5 | 8.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 3.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 3.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 117.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.5 | 2.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 26.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 15.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.5 | 15.3 | GO:0015030 | Cajal body(GO:0015030) |
0.5 | 2.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 2.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 1.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 21.0 | GO:0000792 | heterochromatin(GO:0000792) |
0.4 | 2.6 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.4 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 3.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 1.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 7.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 2.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.4 | 28.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 2.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 4.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 5.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 81.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.4 | 1.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.4 | 7.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 5.1 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 4.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.1 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.4 | 1.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 5.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 1.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 103.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.4 | 4.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 5.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 1.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 5.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 13.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 2.1 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.3 | 1.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 8.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.3 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 4.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 2.0 | GO:0034448 | EGO complex(GO:0034448) |
0.3 | 1.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 16.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 4.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 8.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 19.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.3 | 3.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 20.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 2.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 1.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 5.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.4 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 11.6 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 1.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 2.1 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 20.5 | GO:0005814 | centriole(GO:0005814) |
0.3 | 1.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 4.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 0.3 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.3 | 2.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.3 | 1.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 1.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 4.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 2.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 28.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 4.1 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 3.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 12.9 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 22.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 1.1 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 1.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 1.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 1.0 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 5.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 3.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 3.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 12.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 3.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 2.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 11.2 | GO:0016605 | PML body(GO:0016605) |
0.2 | 2.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 4.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 3.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 2.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 3.0 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 1.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 3.6 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.3 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 0.9 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.7 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 40.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 16.1 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.7 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 4.7 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 3.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.0 | 39.1 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
11.7 | 35.0 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
11.5 | 69.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
11.4 | 45.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
9.6 | 28.9 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
8.9 | 17.8 | GO:0048030 | disaccharide binding(GO:0048030) |
8.8 | 26.4 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
8.5 | 51.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
8.4 | 25.3 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
8.1 | 24.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
7.9 | 39.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
7.8 | 39.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
7.6 | 22.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
7.5 | 45.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
6.7 | 40.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
6.5 | 32.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
6.0 | 18.1 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
6.0 | 24.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
5.7 | 22.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
5.4 | 16.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
5.2 | 20.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
5.2 | 20.6 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
4.8 | 14.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
4.7 | 47.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
4.7 | 18.7 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
4.5 | 89.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
4.4 | 13.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.4 | 13.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
4.4 | 26.2 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
4.3 | 30.3 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
4.3 | 17.1 | GO:0070976 | TIR domain binding(GO:0070976) |
4.1 | 12.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
4.0 | 36.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
4.0 | 20.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
4.0 | 12.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
3.9 | 35.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
3.9 | 11.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
3.9 | 15.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
3.8 | 11.4 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
3.7 | 33.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.7 | 40.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
3.5 | 17.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
3.5 | 17.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
3.4 | 13.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
3.4 | 10.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
3.3 | 10.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
3.3 | 78.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
3.3 | 9.8 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
3.3 | 29.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
3.3 | 9.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
3.3 | 58.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
3.3 | 13.0 | GO:0030519 | snoRNP binding(GO:0030519) |
3.2 | 16.0 | GO:0030911 | TPR domain binding(GO:0030911) |
3.2 | 123.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
3.1 | 9.4 | GO:0019978 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
3.1 | 9.4 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
3.1 | 9.3 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
3.1 | 15.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
3.0 | 12.2 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
3.0 | 6.0 | GO:0031014 | troponin T binding(GO:0031014) |
3.0 | 12.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
3.0 | 8.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
2.9 | 8.7 | GO:0002055 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
2.9 | 20.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
2.9 | 45.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.8 | 11.1 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
2.8 | 8.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
2.7 | 5.4 | GO:0034046 | poly(G) binding(GO:0034046) |
2.7 | 16.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
2.7 | 5.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
2.7 | 16.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.7 | 8.0 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
2.6 | 18.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
2.6 | 18.4 | GO:0031013 | troponin I binding(GO:0031013) |
2.6 | 131.4 | GO:0003785 | actin monomer binding(GO:0003785) |
2.6 | 20.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
2.6 | 20.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
2.6 | 15.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.6 | 5.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
2.6 | 10.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.6 | 7.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
2.5 | 45.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
2.5 | 7.6 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.5 | 27.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
2.4 | 31.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.4 | 14.5 | GO:0048495 | Roundabout binding(GO:0048495) |
2.4 | 9.6 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
2.4 | 21.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.4 | 2.4 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
2.4 | 9.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
2.4 | 16.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.3 | 11.6 | GO:1990188 | euchromatin binding(GO:1990188) |
2.3 | 25.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.3 | 16.0 | GO:0043515 | kinetochore binding(GO:0043515) |
2.3 | 6.8 | GO:0003896 | DNA primase activity(GO:0003896) |
2.3 | 11.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.2 | 6.7 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
2.2 | 35.6 | GO:1990405 | protein antigen binding(GO:1990405) |
2.2 | 40.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
2.2 | 17.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
2.2 | 6.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.2 | 21.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
2.1 | 87.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
2.1 | 16.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
2.1 | 10.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
2.1 | 6.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.1 | 14.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.1 | 6.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
2.1 | 10.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.1 | 24.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
2.1 | 8.3 | GO:0043532 | angiostatin binding(GO:0043532) |
2.1 | 12.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
2.0 | 12.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
2.0 | 2.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
2.0 | 14.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.0 | 24.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.0 | 10.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.0 | 8.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.0 | 8.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
2.0 | 14.0 | GO:0051425 | PTB domain binding(GO:0051425) |
2.0 | 2.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
2.0 | 7.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
2.0 | 11.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
2.0 | 7.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.9 | 97.3 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
1.9 | 7.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.9 | 13.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.9 | 5.8 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
1.9 | 25.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.9 | 15.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.9 | 30.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.9 | 5.6 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
1.9 | 7.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.8 | 7.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.8 | 5.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.8 | 17.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.8 | 21.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.8 | 14.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.7 | 38.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.7 | 97.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.7 | 29.6 | GO:0005522 | profilin binding(GO:0005522) |
1.7 | 5.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
1.7 | 3.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.7 | 8.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.7 | 1.7 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
1.7 | 27.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.7 | 5.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.7 | 6.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.7 | 3.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.7 | 10.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.7 | 1.7 | GO:0032356 | oxidized DNA binding(GO:0032356) |
1.7 | 31.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.7 | 1.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.7 | 5.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.6 | 49.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.6 | 4.9 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
1.6 | 6.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.6 | 1.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.6 | 1.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.6 | 11.2 | GO:0035197 | siRNA binding(GO:0035197) |
1.6 | 47.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.6 | 8.0 | GO:2001069 | glycogen binding(GO:2001069) |
1.6 | 44.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.6 | 6.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.6 | 9.4 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
1.6 | 7.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.5 | 4.6 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
1.5 | 15.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
1.5 | 13.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.5 | 8.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.5 | 34.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.5 | 131.4 | GO:0030507 | spectrin binding(GO:0030507) |
1.5 | 14.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.5 | 4.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.5 | 4.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.4 | 4.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.4 | 8.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.4 | 4.3 | GO:0070052 | collagen V binding(GO:0070052) |
1.4 | 36.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.4 | 25.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.4 | 5.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
1.4 | 1.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
1.4 | 13.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.4 | 9.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.4 | 4.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
1.4 | 1.4 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
1.4 | 1.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.4 | 19.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.4 | 5.5 | GO:0004335 | galactokinase activity(GO:0004335) |
1.4 | 6.8 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.3 | 13.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.3 | 7.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.3 | 19.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.3 | 5.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.3 | 11.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.3 | 6.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.3 | 3.9 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
1.3 | 3.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.3 | 9.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.3 | 10.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.3 | 3.9 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
1.3 | 7.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 3.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.3 | 3.8 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
1.3 | 156.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.3 | 13.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.3 | 7.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.3 | 2.5 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.2 | 19.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.2 | 6.1 | GO:0034452 | dynactin binding(GO:0034452) |
1.2 | 12.3 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.2 | 39.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.2 | 12.2 | GO:0004064 | arylesterase activity(GO:0004064) |
1.2 | 2.4 | GO:0036004 | GAF domain binding(GO:0036004) |
1.2 | 3.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
1.2 | 16.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.2 | 1.2 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
1.2 | 14.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.2 | 11.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.2 | 1.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
1.2 | 17.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.2 | 7.0 | GO:0070728 | leucine binding(GO:0070728) |
1.2 | 5.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.2 | 29.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.2 | 2.3 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
1.1 | 16.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.1 | 26.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.1 | 4.6 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
1.1 | 10.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.1 | 36.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.1 | 3.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.1 | 2.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.1 | 4.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 8.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
1.1 | 1.1 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
1.1 | 4.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.1 | 39.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.1 | 7.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
1.1 | 4.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.1 | 1.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.1 | 10.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.1 | 16.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.1 | 3.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.1 | 4.3 | GO:0031996 | thioesterase binding(GO:0031996) |
1.1 | 8.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.1 | 11.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.1 | 10.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.1 | 4.3 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
1.1 | 13.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.1 | 33.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.1 | 46.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.1 | 4.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.1 | 28.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.1 | 25.3 | GO:0005521 | lamin binding(GO:0005521) |
1.0 | 5.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.0 | 33.4 | GO:0070840 | dynein complex binding(GO:0070840) |
1.0 | 24.9 | GO:0030506 | ankyrin binding(GO:0030506) |
1.0 | 2.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.0 | 21.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.0 | 5.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.0 | 1.0 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.0 | 24.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.0 | 6.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
1.0 | 2.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 7.0 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.0 | 4.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.0 | 1.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.0 | 63.6 | GO:0019209 | kinase activator activity(GO:0019209) |
1.0 | 23.2 | GO:0051861 | glycolipid binding(GO:0051861) |
1.0 | 31.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.0 | 2.9 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.9 | 12.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.9 | 3.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.9 | 6.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.9 | 5.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.9 | 41.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.9 | 11.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.9 | 21.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.9 | 2.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.9 | 5.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.9 | 4.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.9 | 9.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 2.7 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.9 | 35.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.9 | 53.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.9 | 12.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.9 | 11.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 8.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 160.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.9 | 2.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.9 | 42.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.9 | 50.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.9 | 7.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.9 | 5.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 5.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 4.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.9 | 5.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 3.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.9 | 6.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.8 | 7.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 2.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.8 | 6.7 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 1.7 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.8 | 44.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.8 | 4.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.8 | 25.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.8 | 4.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) acylglycerol O-acyltransferase activity(GO:0016411) |
0.8 | 1.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.8 | 6.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.8 | 7.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.8 | 7.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.8 | 0.8 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.8 | 5.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.8 | 2.3 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.8 | 6.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 6.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.8 | 36.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.8 | 35.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.8 | 5.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.8 | 2.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.8 | 6.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 11.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 4.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.7 | 3.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.7 | 5.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 2.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 2.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 147.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.7 | 2.1 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
0.7 | 5.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.7 | 14.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 2.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.7 | 2.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 8.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.7 | 2.8 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.7 | 13.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.7 | 17.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 7.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.7 | 2.8 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.7 | 2.8 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.7 | 2.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 6.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.7 | 9.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.7 | 13.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 2.8 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.7 | 18.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.7 | 6.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 18.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 2.7 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.7 | 2.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.7 | 2.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.7 | 2.0 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.7 | 1.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.7 | 2.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 3.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.7 | 129.0 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 13.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.7 | 3.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.7 | 3.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 2.6 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.6 | 3.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 5.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 3.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 4.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 1.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 3.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 3.7 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.6 | 4.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 1.8 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
0.6 | 1.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.6 | 1.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.6 | 4.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 4.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.6 | 1.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.6 | 9.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.6 | 7.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 2.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.6 | 2.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 3.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 4.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 16.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 4.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 12.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.6 | 1.7 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.6 | 4.6 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.6 | 1.1 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.6 | 16.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.6 | 17.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 1.7 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.6 | 30.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 3.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 187.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 1.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.5 | 5.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 2.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 1.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.5 | 5.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 22.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 14.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 2.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 3.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 1.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 4.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 1.6 | GO:0031208 | POZ domain binding(GO:0031208) |
0.5 | 19.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.5 | 3.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 1.6 | GO:0008456 | alpha-galactosidase activity(GO:0004557) alpha-N-acetylgalactosaminidase activity(GO:0008456) |
0.5 | 13.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 12.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.5 | 30.3 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 1.5 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.5 | 6.6 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 27.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 1.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.5 | 7.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 20.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 6.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 25.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.5 | 1.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.5 | 3.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 3.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.5 | 1.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.5 | 16.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.5 | 5.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 3.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.5 | 1.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.5 | 17.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 5.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 4.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 32.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 1.9 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.5 | 1.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.5 | 1.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 3.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.5 | 3.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 4.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.5 | 4.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.4 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.5 | 3.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 219.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.4 | 14.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 11.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 2.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 1.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.4 | 7.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.4 | 5.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 11.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 41.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.4 | 4.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 9.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 0.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 3.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 1.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 2.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 1.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.4 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 4.4 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.4 | 16.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 23.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 2.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 3.5 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.4 | 37.2 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 1.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.4 | 1.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 14.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.4 | 2.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 1.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.4 | 3.0 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 9.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 15.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 1.8 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 1.8 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.4 | 3.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 5.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 5.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 23.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 1.8 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 3.9 | GO:0008061 | chitin binding(GO:0008061) |
0.4 | 54.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.4 | 1.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 6.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 2.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 3.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 2.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 20.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 1.3 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.3 | 1.3 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.3 | 6.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 1.3 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.3 | 2.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 2.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 2.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 2.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 4.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.3 | 8.4 | GO:0004532 | exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.3 | 2.4 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.3 | 0.9 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 3.0 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.3 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 1.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 3.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 5.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 2.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 3.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.3 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 9.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 3.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 1.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.3 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.3 | GO:0070401 | NADP+ binding(GO:0070401) |
0.3 | 3.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 5.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 7.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 0.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.3 | 1.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 7.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 2.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 1.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.3 | 0.5 | GO:0031711 | mitogen-activated protein kinase kinase binding(GO:0031434) bradykinin receptor binding(GO:0031711) |
0.3 | 2.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 20.6 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 1.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 25.0 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.0 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.2 | 2.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.9 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.2 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.2 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 12.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 1.1 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.2 | 3.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 1.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.2 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 3.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.4 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.2 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 24.3 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 2.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 1.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 4.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 2.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 4.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 35.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 1.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 2.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 2.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 1.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.2 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 3.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.2 | 2.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 1.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 2.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.2 | 18.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 1.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 3.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.7 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 13.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 2.5 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 1.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 15.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.4 | GO:0035516 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
0.1 | 0.4 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 19.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 2.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 6.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 3.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.0 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.4 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 2.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.5 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.4 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.4 | GO:0086077 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 2.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 3.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.5 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 9.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 1.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.1 | 2.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 8.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 5.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 6.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 1.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 1.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 3.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 1.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 3.4 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.0 | GO:0003681 | bent DNA binding(GO:0003681) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 55.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
5.5 | 104.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
3.6 | 206.7 | PID AURORA B PATHWAY | Aurora B signaling |
3.6 | 7.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
3.3 | 3.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
3.2 | 186.6 | PID PLK1 PATHWAY | PLK1 signaling events |
2.3 | 52.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.1 | 125.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.9 | 39.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.8 | 78.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.7 | 11.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.7 | 92.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.6 | 67.6 | PID ATR PATHWAY | ATR signaling pathway |
1.6 | 124.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.6 | 144.4 | PID E2F PATHWAY | E2F transcription factor network |
1.6 | 46.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.5 | 7.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.5 | 56.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.5 | 24.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.5 | 20.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.4 | 36.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.4 | 1.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.4 | 31.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.3 | 5.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.2 | 83.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.2 | 50.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.2 | 125.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.1 | 28.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.1 | 11.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.1 | 28.1 | PID ATM PATHWAY | ATM pathway |
1.1 | 75.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 36.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.1 | 27.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.1 | 26.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.1 | 3.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.1 | 41.3 | PID RAS PATHWAY | Regulation of Ras family activation |
1.0 | 29.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.0 | 3.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.0 | 39.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 6.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.9 | 8.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.9 | 33.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.8 | 5.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 25.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.8 | 13.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.8 | 1.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.8 | 19.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.8 | 14.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 12.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 8.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.7 | 18.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 18.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 11.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 4.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 15.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.7 | 41.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.7 | 12.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.6 | 4.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 17.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.6 | 38.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 7.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 9.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 3.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.6 | 29.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 18.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 1.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 11.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 27.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 8.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 24.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.5 | 3.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 6.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 15.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 38.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.5 | 14.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 3.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 5.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 2.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 16.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 13.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 25.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 3.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 12.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 6.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 2.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.4 | 3.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 3.6 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 27.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 8.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 10.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 1.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 2.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 40.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 2.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 17.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 14.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 1.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 15.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 8.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 8.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 12.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 7.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 4.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 5.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 3.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 8.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 12.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 8.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 5.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 5.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 85.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
6.2 | 43.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
5.7 | 34.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
5.2 | 73.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
4.5 | 58.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
4.2 | 75.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
4.1 | 91.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
3.9 | 93.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.8 | 19.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
3.7 | 40.9 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
3.6 | 58.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.6 | 58.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
3.4 | 10.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
3.4 | 74.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.3 | 59.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
3.2 | 22.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
3.1 | 77.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
3.0 | 14.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.7 | 35.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.7 | 107.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.6 | 41.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.4 | 41.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
2.4 | 2.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.3 | 30.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
2.1 | 16.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
2.0 | 52.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.0 | 63.8 | REACTOME KINESINS | Genes involved in Kinesins |
1.9 | 232.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.9 | 28.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.9 | 109.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.8 | 52.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.7 | 17.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.7 | 133.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.7 | 85.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.7 | 76.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.7 | 13.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.6 | 47.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.6 | 33.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.6 | 65.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.6 | 28.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.6 | 41.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
1.6 | 34.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.5 | 28.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.5 | 32.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.4 | 40.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
1.4 | 39.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.4 | 64.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.4 | 59.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.4 | 39.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.4 | 87.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.3 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.3 | 30.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.3 | 14.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.3 | 22.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.3 | 1.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.3 | 1.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.3 | 16.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.3 | 14.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.3 | 14.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.2 | 82.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.2 | 51.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.1 | 25.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.1 | 7.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.1 | 23.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.1 | 55.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.1 | 1.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.1 | 36.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.1 | 1.1 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
1.1 | 9.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.1 | 24.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.1 | 31.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.1 | 1.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.0 | 21.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.0 | 28.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.0 | 6.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.0 | 21.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.0 | 58.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
1.0 | 13.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 2.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 15.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.9 | 41.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.9 | 11.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 25.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.9 | 21.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 11.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.8 | 10.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.8 | 35.3 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.8 | 4.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 83.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.8 | 16.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.8 | 17.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.8 | 21.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.8 | 10.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 21.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.7 | 6.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.7 | 15.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 0.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.7 | 3.7 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.7 | 25.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.7 | 77.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.7 | 20.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.7 | 9.0 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.7 | 21.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.7 | 5.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.7 | 2.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 59.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 19.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 14.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.6 | 13.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 20.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.6 | 4.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.6 | 10.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 1.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.6 | 20.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 8.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 4.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 13.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 9.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.5 | 7.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.5 | 7.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.5 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 9.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 3.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.5 | 1.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 3.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 2.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 25.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 7.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 7.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 8.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 8.5 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.4 | 6.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 18.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 0.4 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.4 | 3.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 12.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 9.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 3.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 3.9 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 1.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 3.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 104.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 15.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 20.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 2.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 1.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 3.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 6.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 2.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 2.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 4.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 5.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 3.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 8.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 17.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 6.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 16.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 14.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.7 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 3.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |